Aptinyx Inc reported $77.48M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Acorda Therapeutics ACOR:US $ 87.91M 39.64M
Biogen BIIB:US $ 11872.5M 630.2M
Cara Therapeutics CARA:US $ 204.11M 23.41M
Daiichi Sankyo 4568:JP Y 1400252M 49380M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Halozyme Therapeutics HALO:US $ 260.26M 63.3M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Marinus Pharmaceuticals MRNS:US $ 40.4M 13.08M
Neurocrine Biosciences NBIX:US $ 1423.4M 32.3M
Novartis NOVN:VX SF 62925M 1385M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
Vertex Pharmaceuticals VRTX:US $ 11933.5M 1026.5M